George Brady

(The following information was supplied by the firm)

George is a partner in the firm’s Corporate Department. He has advised on many of the most significant Irish corporate transactions of recent years including:

• Allergan’s $66 billion merger with Actavis.
• Unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group.
• The Actavis $8.5 billion acquisition of Warner Chilcott.
• The $6.5 billion hostile bid by Royalty Pharma for Elan Corporation.
• Medtronic’s proposed $42.9 billion acquisition of Covidien plc.
• Eaton Corporation’s $11.8 billion acquisition of Cooper Industries.
• The $5.6 billion merger of Questcor and Mallinckrodt.
• Babcock & Brown on its €2.3 billion acquisition of eircom.
• The $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International.

George previously worked in the London office of a leading international law firm and has been a partner since 2003.